Rosiglitazone plus gliclazide improves glycaemia in Type 2 diabetics compared to doubling the gliclazide dose

被引：0
|
作者：
James, RE
Wright, S
Zhou, B
Mather, RA
Jones, NP
机构：
[1] SmithKline Beecham, Harlow, Essex, England
[2] SmithKline Beecham, Collegeville, PA USA
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
895
引用
下载
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [1] Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes
    Vilar, Lucio
    Canadas, Viviane
    Arruda, Maria Juliana
    Arahata, Carla
    Agra, Rodrigo
    Pontes, Lisete
    Montenegro, Larissa
    Vilar, Clarice Freitas
    Moura e Silva, Lidiane
    Albuquerque, Jose Luciano
    Gusmao, Amaro
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (03) : 311 - 318
  • [2] Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea
    Baksi, A
    James, RE
    Zhou, B
    Nolan, JJ
    ACTA DIABETOLOGICA, 2004, 41 (02) : 63 - 69
  • [3] Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea
    A. Baksi
    R. E. James
    B. Zhou
    J. J. Nolan
    Acta Diabetologica, 2004, 41 : 63 - 69
  • [4] Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients
    Chen, Lu-lu
    Liao, Yun-fei
    Zeng, Tian-shu
    Yu, Fan
    Li, Hui-qing
    Feng, Yong
    ENDOCRINE, 2010, 38 (02) : 266 - 275
  • [5] Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients
    Lu-lu Chen
    Yun-fei Liao
    Tian-shu Zeng
    Fan Yu
    Hui-qing Li
    Yong Feng
    Endocrine, 2010, 38 : 266 - 275
  • [6] Evaluation of glycemic control with rosiglitazone add-on therapy in failing gliclazide monotherapy: A randomized study in obese type 2 diabetics of North India.
    Dhingra, Mandeep Singh
    Singh, Jatinder
    Multani, Amrik Singh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1062 - 1062
  • [7] Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients
    Güvener, N
    Gedik, O
    ACTA DIABETOLOGICA, 1999, 36 (1-2) : 93 - 97
  • [8] Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients
    N. Güvener
    O. Gedik
    Acta Diabetologica, 1999, 36 : 93 - 97
  • [9] Rosiglitazone plus 7.5 mg glibenclamide improves glycemia in individuals with type 2 diabetes compared to increasing the glibenclamide dose to 15 mg
    Kerenyi, Z
    Samer, H
    James, R
    Yan, Y
    Stewart, M
    DIABETES, 2003, 52 : A449 - A449
  • [10] Rosiglitazone improves postprandial glycaemia and markers of endothelial function in patients with Type 2 diabetes
    Agrawal, A
    Chen, H
    Yan, Y
    Mather, R
    Albertini, JP
    Valensi, P
    Hanefeld, M
    DIABETOLOGIA, 2002, 45 : A251 - A251
12345